Posts by: Steve Bryson PhD

Steve Bryson PhD

October 21, 2019October 21, 2019

Survival Rates Over Time Similar for IPF Patients Given Single or Double Lung Transplant, Study Finds

News

No significant differences in survival rates, extending out 10 years, were found in idiopathic pulmonary fibrosis (IPF) patients given either a single- or double-lung transplant, a study reports. These findings, based ... Read more

September 18, 2019September 18, 2019

Simultaneous Inhibition of TGF-beta1, Periostin Signals Can Halt PF Progression in Mice, Study Shows

News

Simultaneous inhibition of two signaling pathways mediated by TGF-beta1 and periostin can halt progression of idiopathic pulmonary fibrosis in mice, a new study reveals. The study, “The Cross-Talk Between ... Read more

September 16, 2019September 16, 2019

Screening for Mucin Gene Mutation May Lead to Personalized IPF Prevention Therapy, Researcher Says

News

Genetic screening that can identify variants of the mucin-causing MUC5B gene — the key risk factor that predisposes people for idiopathic pulmonary fibrosis (IPF) — may hold the key to the ... Read more

August 28, 2019August 28, 2019

Ceapro and McMaster University Researchers Awarded $500K to Optimize IPF Treatments

News

Efforts to optimize treatments to address critical challenges in treating idiopathic pulmonary fibrosis (IPF) has been given a boost by a more than CA$670,000 grant to support a collaborative project ... Read more

August 23, 2019August 27, 2019

Inflammatory Bowel Disease Linked to Higher Risk of IPF, Population Study Shows

News

Inflammatory bowel disease (IBD) increases the risk of developing idiopathic pulmonary fibrosis (IPF), particularly in male patients with Crohn’s disease, a large-scale population study shows. The study, “Increased Risk ... Read more

August 13, 2019August 13, 2019

Natural Product Tannic Acid Produces Anti-fibrotic Effects in IPF Models, Study Shows

News

The natural product tannic acid has anti-fibrotic effects on cultured human lung fibroblasts and in an in vivo idiopathic pulmonary fibrosis (IPF) mouse model by reducing signals from TGF-beta receptors, ... Read more

July 30, 2019August 2, 2019

PFF Care Center Network Expands to 33 US States with Addition of 8 Treatment Facilities

News

The Pulmonary Fibrosis Foundation (PFF) announced that its nationwide Care Center Network (CCN) now encompasses 68 medical centers in 33 states, following the addition of eight sites with recognized expertise ... Read more

Pin It on Pinterest